| ABBOTT LABORATORIES www.abbott.com | | Industry Group Code: 325412 | | | | Ranks within this company's industry group: | | Sales: 8 | Profits:10 |
| | | Insurance/HMO/PPO: | | Insurance: | | | Managed Care: | | | Utilization Management: | | | Payment Processing: | | | | | | | |
| | Drugs: | | Manufacturer: | Y | | Distributor: | | | Specialty Pharmacy: | | | Vitamins/Nutritionists: | Y | | Clinical Trials: | | | | |
| | Equipment/Supplies: | | Manufacturer: | Y | | Distributor: | | | Leasing/Finance: | | | Information Systems: | | | | | |
| | Hospitals/Clinics: | | Acute Care: | | | Sub-Acute Care: | | | Outpatient Surgery: | | | Physical Rehab. Ctr.: | | | Psychiatric Clinics: | | | |
| | Services: | | Diagnostics: | | | Labs/Testing: | | | Staffing: | | | Waste Disposal: | | | Specialty Services: | | | | |
| | Health Care: | | Home Health: | | | Long-Term Care: | | | Physical Therapy: | | | Physician Prac. Mgmt.: | | | | | |
|
| TYPES OF BUSINESS: | BRANDS/DIVISIONS/AFFILIATES | Pharmaceuticals Manufacturing
Nutritional Products
Diagnostics
Consumer Health Products
Medical & Surgical Devices
Pharmaceutical Products
Animal Health
|
| Abbott Medical Optics Inc
Prevacid
Lupix
Trilipix
Humira
Simcor
Glucerna
Ensure
| | CONTACTS: Note: Officers with more than one job title may be intentionally listed here more than once. | Miles D. White, CEO
Thomas C. Freyman, CFO
Stephen R. Fussell, Sr. VP-Human Resources
John M. Leonard, Sr. VP-R&D
John C. Landgraf, Sr. VP-Global Pharmaceutical Mgmt. & Supply
Laura J. Schumacher, General Counsel/Exec. VP/Corp. Sec.
Richard W. Ashley, Exec. VP-Corp. Dev.
Melissa Brotz, VP-External Comm.
Thomas C. Freyman, Exec. VP-Finance
James L. Tyree, Exec. VP-Pharmaceutical Products Group
Holger Liepmann, Exec. VP-Global Nutrition
John M. Capek, Exec. VP-Medical Devices
Michael J. Warmuth, Sr. VP-Diagnostics
Miles D. White, Chmn.
Olivier Bohuon, Sr. VP-Int'l Oper.
| | Phone: 847-937-6100 | | Fax: 847-937-9555 | | Toll-Free: N/A | Address: 100 Abbott Park Rd.
Abbott Park, IL 60064-3500, US |
| | GROWTH PLANS/SPECIAL FEATURES | Abbott Laboratories develops, manufactures and sells health care products and technologies ranging from pharmaceuticals to medical devices. The firm markets its products in more than 130 countries. The pharmaceutical segment deals with adult and pediatric conditions such as rheumatoid arthritis, HIV, epilepsy and manic depression. The diagnostic instruments and test segment deals with a range of medical tests to diagnose infectious diseases, cancer, diabetes and genetic conditions. Products include Humira for arthritis, Prevacid (Ogastro), a proton pump inhibitor for the short-term treatment of gastroesophageal reflux disease and Lupix for prostate cancer. The nutritional products segment offers consumer products such as Similac, Ensure, Glucerna and AdvantEdge, as well as medical nutritional products and feeding devices. The diagnostic products segment includes diagnostic systems and tests such as immunoassay, chemistry and hematology systems, which are manufactured, marketed and sold to blood banks, hospitals, commercial laboratories, physicians’ offices and plasma protein therapeutic companies. The vascular products segment consists of coronary, endovascular and vessel closure devices, used in the treatment of vascular disease. These products are generally marketed and sold directly to hospitals from Abbot-owned distribution centers and public warehouses. The firm also produces a line of animal products such as anesthetics, wound care products and intravenous fluid therapy for the veterinary market. The company operates internationally in Europe, Asia, Africa, Latin and South America and the Middle East. In December 2008, Abbott received FDA approval for Trilipix, a cholesterol management medication. In February 2009, the company acquired Advanced Medical Optics which has since been renamed Abbott Medical Optics Inc. In September of the same year, the firm agreed to acquire the pharmaceutical unit of Belgian company, Solvay SA for $7 billion.
Employees are offered medical, dental and vision insurance; flexible spending accounts; child care solutions; an employee assistance program; legal referral services; a pension plan; a 401(k) plan; profit sharing; tuition assistance; travel accident insurance; long-term care insurance; and life insurance. |
| FINANCIALS: Sales and profits are in thousands of dollars-add 000 to get the full amount. Yr. 2009 note: Fiscal 2009 results were not available for all companies at press time. For this company, yr. 2009 is for months. | | 2009 Sales: | | ( months) | 2009 Profits: | | ( months) | | 2008 Sales: | $29,527,600 | | 2008 Profits: | $4,880,700 | | | 2007 Sales: | $25,914,200 | | 2007 Profits: | $3,606,300 | | | 2006 Sales: | $22,476,322 | | 2006 Profits: | $1,716,255 | | | 2005 Sales: | $22,337,808 | | 2005 Profits: | $3,372,065 | | Stock Ticker: ABT | Employees: 69,000 | Fiscal Year Ends: 12/31 |
| SALARIES/BENEFITS: | | Pension Plan: Y | ESOP Stock Plan: | Profit Sharing: Y | | Savings Plan: Y | Stock Purch. Plan: | | | | | | Top Exec. Salary: $1,795,471 | Bonus: $4,200,000 | | Second Exec. Salary: $886,363 | Bonus: $1,232,500 |
| OTHER THOUGHTS: | LOCATIONS: ('Y' = YES) | | Apparent Top Female Officers: 5 | W | SW | MW | SE | NE | INTER. | | Hot Spots for Advancement for Women/Minorities: Y | Y | Y | Y |
| Y | Y |
|